BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is a name which comes up in the emerging and speculative biotech takeover list rather frequently, and today we are seeing some interest on speculators. As of 1:10 PM EST we are now more than exponential on the volume alert after a quick CNBC tout by one of the Najarian brothers. We have seen 5.3 million shares versus an average volume of 1.36 million shares. Shares are up almost 10% at $18.03, and the 52-week trading range is $9.93 to $30.74. The SEPT-2009 $17.50 CALLS have traded some 6,365 contracts today, versus an open interest of 344 contracts. Even in the OCT-2009 $17.50 CALLS, these have traded 1,745 contracts today, versus an open interest of 770 contracts.
As our friends noted over at BioMedReports.com, this company is presenting data at the Morgan Stanley Healthcare Conference in New York City on Tuesday, September 15, 2009 at 1:35 p.m. ET.
JON OGG
No comments:
Post a Comment